Relationship between antipsychotic drug use and behavioral and psychological symptoms of dementia in old people with cognitive impairment living in geriatric care

International Psychogeriatrics

Volumn 18, Issue 4, 2006, Pages 713-726

  Lövheim, Hugo ^a   Sandman, Per Olof ^b   Kallin, Kristina ^a   Karlsson, Stig ^a   Gustafson, Yngve ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Aggressiveness; BPSD; Dementia; Nursing home; Pharmacological treatment; Residential care; Sex difference

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

AGED; AGGRESSION; ARTICLE; BEHAVIOR; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DEMENTIA; DISEASE ASSOCIATION; DISRUPTIVE BEHAVIOR; DRUG USE; FEMALE; GERIATRIC CARE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; SWEDEN; WANDERING BEHAVIOR;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; AGGRESSION; ALZHEIMER DISEASE; ANTIPSYCHOTIC AGENTS; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; GROUP HOMES; HOMES FOR THE AGED; HUMANS; LONG-TERM CARE; MALE; MULTIVARIATE ANALYSIS; NURSING HOMES; QUALITY OF LIFE; QUESTIONNAIRES; SEX FACTORS; SOCIAL BEHAVIOR DISORDERS; STATISTICS; SWEDEN;

EID: 33750284946     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610206003930     Document Type: Article

References (29)

1. Adolfsson, R., Gottfries, C. G., Nyström, L. and Winblad, B. (1981). Prevalence of dementia disorders in institutionalized Swedish old people. The work load imposed by caring for these patients. Acta Psychiatrica Scandinavica, 63, 225-244.
2. Ballard, C. and Margallo-Lana, M. (2004). The relationship between antipsychotic treatment and quality of life for patients with dementia living in residential and nursing home care facilities. Journal of Clinical Psychiatry, 65(Suppl. 11), 23-28.
3. Ballard, C. et al. (2001). A 1-year follow-up study of behavioral and psychological symptoms in dementia among people in care environments. Journal of Clinical Psychiatry, 62, 631-636.
4. Ballard, C. et al. (2004). A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome. Journal of Clinical Psychiatry, 65, 114-119.
5. Black, W. and Almeida, O. (2004). A systematic review of the association between the behavioral and psychological symptoms of dementia and burden of care. International Psychogeriatrics, 16, 295-315.
6. Brodaty, H. et al. (2001). Psychosis, depression and behavioral disturbances in Sydney nursing home residents: prevalence and predictors. International Journal of Geriatric Psychiatry, 16, 504-512.
7. Brodaty, H. et al. (2003). A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia. Journal of Clinical Psychiatry, 64, 134-143.
8. Brylewski, J. and Duggan, L. (1999). Antipsychotic medication for challenging behaviour in people with intellectual disability: a systematic review of randomized trials. Journal of Intellectual Disability Research, 43, 360-371.
9. Craig, D. et al. (2003). Factors influencing prescription of CNS medication in different elderly populations. Pharmacoepidemiology and Drug Safety, 12, 383-387.
10. De Deyn, P. et al. (1999). A randomized trial of risperidone, placebo, and haloperidole for behavioral symptoms of dementia. Neurology, 53, 946-955.
11. Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
12. Gormley, N. and Howard, R. (1999). Should neuroleptics be used in the management of nursing home residents with dementia? International Journal of Geriatric Psychiatry, 14, 509-511.
13. Herrmann, N. and Lanctôt, K. (1997). From transmitter to treatment: the pharmacotherapy of behavioral disturbances in dementia. Canadian Journal of Psychiatry, 42, S51-S64.
14. Kallin, K., Gustafson, Y., Sandman, P. O. and Karlsson, S. (2005). Factors associated with falls among older, cognitively impaired people in geriatric care settings: a population-based study. American Journal of Geriatric Psychiatry, 13, 501-509.
15. Katz, I. (2004) Optimizing atypical antipsychotic treatment strategies in the elderly. Journal of the American Geriatrics Society, 52, S272-S277.
16. Lindesay, J., Matthews, R. and Jagger, C. (2003). Factors associated with antipsychotic treatment drug use in residential care: changes between 1990 and 1997. International Journal of Geriatric Psychiatry, 18, 511-519.
17. Liperoti, R., Mor, V. and Lapane, K. (2003). The use of atypical antipsychotics in nursing homes. Journal of Clinical Psychiatry, 64, 1106-1112.
18. Margallo-Lana, M. et al. (2001). Prevalence and pharmacological management of behavioral and psychological symptoms amongst dementia sufferers living in care environments. International Journal of Geriatric Psychiatry, 16, 39-44.
19. Näsman, B., Bucht, G. and Eriksson, S. (1993). Behavioral symptoms in the institutionalized elderly: relationship to dementia. International Journal of Geriatric Psychiatry, 8, 843-849.
20. Pitkala, K. H., Laurila, J. V., Strandberg, T. E. and Tilvis, R. S. (2004). Behavioral symptoms and the administration of psychotropic drugs to aged patients with dementia in nursing homes and acute geriatric wards. International Psychogeriatrics, 16, 61-74.
21. Pollock, B. et al. (2002). Comparison of citalopram, perphenazine, and placebo for acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients. American Journal of Psychiatry, 159, 460-465.
22. Robertson, J., Emerson, E., Gregory, N., Hatton, C., Kessissoglou, S. and Hallam, A. (2000). Receipt of psychotropic medication by people with intellectual disability in residential settings. Journal of Intellectual Disability Research, 44, 666-676.
23. Rovner, B., Steele, C., Schmuely, Y. and Folstein, M. (1996). A randomized trial of dementia care in nursing homes. Journal of the American Geriatrics Society, 44, 7-13.
24. Sandman, P. O., Adolfsson, R., Norberg, A., Nyström, L. and Winblad, B. (1988). Long-term care of the elderly. A descriptive study of 3600 institutionalized patients in the county of Västerbotten, Sweden. Comprehensive Gerontology, 2, 120-132.
25. Sloane, P. et al. (2004). Effect of person-centered showering and the towel bath on bathing-associated aggression, agitation, and discomfort in nursing home residents with dementia: a randomized, controlled trial. Journal of the American Geriatrics Society, 52, 1795-1804.
26. Sørensen, L., Foldspang, A., Gulmann, N. and Munk- Jørgensen, P. (2001). Determinants for the use of psychotropics among nursing home residents. International Journal of Geriatric Psychiatry, 16, 147-154.
27. Statistical Package for Social Sciences Version II (for Mac OSX). SSPS, Chicago, IL, USA.
28. Thapa, P., Meador, K., Gideon, P., Fought, R. and Ray, W. (1994). Effects of antipsychotic withdrawal in elderly nursing home residents. Journal of the American Geriatrics Society, 42, 280-286.
29. World Health Organization (2005). Anatomical Therapeutical Chemical (ATC) (Classification Index Including Defined Daily Doses (DDD) for Plain Substances. Oslo: World Health Organization Collaborating Center for Drug Statistics Methodology.